Myelotoxicity due to methotrexate - an iatrogenic cause.
Saravana
S
S
Lalukotta
K
K
D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007049:Iatrogenic Disease; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D014295:Trimethoprim / Q000627:therapeutic use
D000892:Anti-Infective Agents, Urinary; D018501:Antirheumatic Agents; D005492:Folic Acid; D014295:Trimethoprim; D008727:Methotrexate